In 2004, WHO classified Xp11.2/TFE3 translocation RCC as an independent subtype of renal carcinoma, and in 2016, it was reclassified as microphthalmia‐associated transcription factor (MiTF) RCC subtype.2 This evidence concerns the gene MITF and renal cell carcinoma.